Finland· FI-REL-REL46488
Ciambra
A pemetrexed product containing pemetrexed disodium hemipentahydrate, registered in Finland by Menarini International Operations Luxembourg S.A.. The same ATC class is registered in 17 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Pemetrexed is registered in 17 of 19 countries.
Countries holding a registration under ATC L01BA04 (pemetrexed), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 10 of them publish a price we can compare per daily dose
Pemetrexed · ATC L01BA04
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of pemetrexed costs, country by country.
Normalised to the WHO defined daily dose (43 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Pemetrexed · price per daily dose (43 mg)
USD · FX 28 Sept 2026
- CH Switzerland$49.69
The record
At a glance
Fimea (Finland)- Active substance
- Pemetrexed disodium hemipentahydrate
- Manufacturer
- Menarini International Operations Luxembourg S.A.
- Country
- Finland (FI)
- ATC code
- L01BA04
- ATC class
- Pemetrexed
- Defined daily dose
- 43 mg, P
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
387 interactions on record for pemetrexed.
Graded by severity as the source publishes them — 30 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Pemetrexed · interactions on record
387 records
- 30 severe
- 240 moderate
- 117 info
Most severe, free to view
- CladribineL01BB04severe
- Talimogene laherparepvecL01XL02severe
- CimetidineA02BA01moderate
- RanitidineA02BA02moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Pemetrexed in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumCiambra 500 mgMenarini International Operations Luxembourg
- CzechiaPEMETREXED ACCORDAccord Healthcare S.L.U., Barcelona
- United StatesPemetrexedBluePoint Laboratories
- GermanyPemetrexed StadaStadapharm Gmbh
- IrelandPemetrexed Clonmel 25 mg/ml concentrate for solution for infusionClonmel Healthcare Ltd
- SwedenPemetrexed Zentiva 10 mg/ml Infusionsvätska, lösningZentiva k.s.
Authorised across Europe · EMA
The same active substance is authorised in 10 EEA countries. Names it is sold under:
- Austria · Pemetrexed Zentiva
- Germany · Pemetrexed Stada, Pemetrexed Zentiva
- Denmark · Pemetrexed Zentiva
- Spain · Pemetrexed Prasfarma
- France · Pemetrexed Zentiva
- United Kingdom (Northern Ireland) · Pemetrexed Zentiva
- Netherlands · Pemetrexed Zentiva
- Norway · Pemetrexed Zentiva
- Portugal · Pemetrexedo Stada
- Sweden · Pemetrexed Zentiva
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1f84a7c6-d392-4609-8dbf-a6d24bb96ddf GET /v1/drugs/1f84a7c6-d392-4609-8dbf-a6d24bb96ddf?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "kuiva-aine välikonsentraatiksi infuusionestettä varten, liuos",
"route": "Laskimoon",
"ddd_unit": null,
"strength": "500 mg",
"atc_label": "pemetreksedi",
"ma_number": null,
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": "EU/1/15/1055/002",
"fimea_rel_id": "REL46488",
"authorised_at": "2015-12-02"
}See everything about pemetrexed.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.